Atsunobu Takeda

Dr. Atsunobu Takeda


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2018 in Immunological Medicine
Verified
Journal Article
Open access
KSKota Sato
Kota Sato
ATAtsunobu Takeda
Atsunobu Takeda
EHEiichi Hasegawa
Eiichi Hasegawa
YJYoung-Joon Jo
Young-Joon Jo
MAMitsuru Arima
Mitsuru Arima
KSKoh-Hei Sonoda
Koh-Hei Sonoda
Subretinal fibrosis has been recognized as a feature of an advanced stage of exudative age-related macular degeneration (AMD) that leads to irreversible loss of vision. This study was aimed at elucidating roles of interlukin-6 (IL-6) in the development of subretinal fibrosis. Immunohistochemistry (IHC) was performed with anti-human IL-6 antibody in surgically excised choroidal neovascular tissues from patients with exudative AMD. The area of subretinal fibrosis was measured in a mouse subretinal fibrosis model with injection of control small interfering RNA(siRNA) or IL-6 siRNA, or isotype control antibody or anti-IL-6 receptor antibody after peritoneal exudative cells (PECs) injection into the vitreous cavity. PECs derived from IL-6+/+ or IL-6−∕− mice were placed into the subretinal space of IL-6+/+ mice. IL-6 was expressed in the stroma and retinal pigment epithelial (RPE) layer in the choroidal neovascular tissues. IL-6 knockdown or blocking of the IL-6 receptor suppressed the formation of subretinal fibroblastic scars. The area of subretinal fibrosis induced by PECs derived from IL-6−∕− mice was less than that induced by PECs from IL-6+/+ mice. The results suggested that IL-6, expressed by activated macrophages, is a crucial mediator that promotes subretinal fibrosis. Targeting IL-6 and the corresponding signaling pathway would be an attractive therapeutic approach not only in choroidal neovascularization, but also in subretinal fibrosis.

1 November 2015 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Closed access
PDF file
ATAtsunobu Takeda
Atsunobu Takeda
HYHiroshi Yoshikawa
Hiroshi Yoshikawa
TFTakako Fukuhara
Takako Fukuhara
SHShin-Ichi Hikita
Shin-Ichi Hikita
KHKuniaki Hijioka
Kuniaki Hijioka
TITatsuro Ishibashi
Tatsuro Ishibashi
Purpose: To determine the profiles of soluble cytokine receptors and cytokines, including mostly their ligands, in the vitreous humor of patients with B-cell vitreoretinal lymphoma (VRL) and uveitis. Methods: Vitreous samples were collected from immunocompetent patients with VRL (n = 21), uveitis (n = 20), and idiopathic epiretinal membrane (n = 21) as controls. Cytometric beads assay were used to determine the vitreous concentrations of soluble receptors and cytokines. Results: Vitreous levels of soluble IL-2 receptor α (sIL-2Rα), sIL-6R, soluble tumor necrosis factor receptor (TNFR) 1, sTNFR2, soluble vascular endothelial growth factor receptor (sVEGFR) 1, sVEGFR2, and IL-10 were higher in patients with VRL than in those with uveitis and controls, whereas those of sIL-1R1, sIL-1R2, and sIL-4R were higher in patients with uveitis than those with VRL and controls. In analyses in patients with VRL, elevation of sVEGFR1 and sVEGFR2 levels was more prominent in patients with systemic metastatic retinal lymphoma (SMRL) than in those with primary VRL/primary central nervous system lymphoma (PVRL/PCNSL). Furthermore, sIL-2Rα levels were increased in patients with VRL who developed subretinal lesions compared with in those who mainly had vitreous cavity opacity, positively correlated with the density of CD3+ cells in the vitrectomy cell blocks. Conclusions: The profiles of soluble cytokine receptors and cytokines in patients with VRL were different from those with uveitis. In addition, sVEGFR1 and sVEGFR2 levels may be differential diagnostic markers between PVRL/PCNSL and SMRL, and sIL-2Rα levels can anticipate infiltration of VRL cells into the subretina and/or retina.

1 November 2011 in Journal of Leukocyte Biology
Verified
Journal Article
Open access
PDF file
EHEiichi Hasegawa
Eiichi Hasegawa
YOYuji Oshima
Yuji Oshima
ATAtsunobu Takeda
Atsunobu Takeda
KSKazuko Saeki
Kazuko Saeki
HYHiroki Yoshida
Hiroki Yoshida
TITatsuro Ishibashi
Tatsuro Ishibashi
AMD is the most common disease leading to acquired blindness in developed countries. CNV is the foremost cause of AMD and is thought to be induced by regional inflammation as a result of age-related conformational changes of the chorioretinal interface. Here, we show that IL-27, a member of the IL-6/IL-12 cytokine family, has an angiostatic effect and regulates the development of laser-induced experimental CNV in mice. In this model, IL-27 expression increased in the damaged choroid and peaked at the 24 h-time-point. IL-27 neutralization, induced by inoculating an antagonistic antibody into the vitreous cavity, enhanced VEGF production and the extent of CNV. By contrast, the administration of rIL-27 reduced VEGF production and the extent of CNV. Mice deficient in the EBI3, which lack IL-27, also showed more CNV than C57BL/6 mice, and this was reduced by IL-27 supplementation. We additionally investigated the effect of IL-27 on the function of macrophages, which play a critical role in CNV. IL-27 did not affect macrophage migration but inhibited its VEGF production. IL-27 therefore appears to regulate CNV and is a promising candidate target for treating sight-threatening diseases caused by ocular neovascularization.

23 March 2018 in Japanese Journal of Ophthalmology
Verified
Journal Article
Closed access
PDF file
ATAtsunobu Takeda
Atsunobu Takeda
HYHisakata Yamada
Hisakata Yamada
EHEiichi Hasegawa
Eiichi Hasegawa
MAMitsuru Arima
Mitsuru Arima
SNShoji Notomi
Shoji Notomi
KSKoh-Hei Sonoda
Koh-Hei Sonoda

13 March 2019 in Graefe's Archive for Clinical and Experimental Ophthalmology
Verified
Journal Article
Closed access
PDF file
TITakako Ito
Takako Ito
ATAtsunobu Takeda
Atsunobu Takeda
KFKohta Fujiwara
Kohta Fujiwara
EHEiichi Hasegawa
Eiichi Hasegawa
SNShintaro Nakao
Shintaro Nakao
KSKoh-Hei Sonoda
Koh-Hei Sonoda

11 October 2016 in Ocular Immunology and Inflammation
Verified
Journal Article
Closed access
ATAtsunobu Takeda
Atsunobu Takeda
TITatsuro Ishibashi
Tatsuro Ishibashi
KSKoh-Hei Sonoda
Koh-Hei Sonoda
Ethnicity, geography, and socioeconomic factors are among the aspects influencing the prevalence of uveitis in specific areas and countries. Human T-lymphotropic virus type 1-associated uveitis and ocular toxoplasmosis are endemic to Southern Kyushu, the southern-most region of Japan. Recent reports have postulated that the prevalence of intraocular tuberculosis is increasing in Tokyo. This review focuses on local factors that affect the three major vectors for infectious endemic uveitis in Japan, as well as their routes of transmission and factors for improving diagnoses. This information will facilitate the promotion of public health measures aimed at decreasing uveitis prevalence in Japan.